House Republicans Aim To Eliminate Tax Credits For Orphan Drugs
For more than three decades, pharmaceutical companies have claimed a 50 percent tax credit for the cost of clinical trials of drugs for rare diseases. The credit is now in jeopardy.
Read more on NPR
No comments:
Post a Comment